ProCE Banner Activity

Experts Address Questions on Therapeutic Targeting of CD47 in MDS and AML

Clinical Thought

In this commentary, Naval G. Daver, MD, and Amer Zeidan, MBBS, answer questions on targeting CD47 in MDS and AML posed by healthcare professionals in the audience at a live symposium.

Released: July 19, 2023


Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


This program has been supported by an independent educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.